Afuco™ Anti-KC4 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-KC4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The murine monoclonal antibodies targeting KC4 which is specific for thrombin-activated platelets can be used for cancer treatment.
Supplier Creative Biolabs
Product # AFC-742CL
Pricing Inquiry
Type ADCC enhanced antibody
Storage Store at -20°C. Avoid multiple freeze/thaw cycles.
Host Humanized
Target KC4
Feedback